It was first recognized in the 1930s that cancer cells use glucose differently to normal cells, but these differences are yet to be exploited for therapeutic purposes. This lecture will describe the different metabolic needs of cancer cells, and how redirecting cancer metabolism towards a more normal pattern can change cancer cell behaviour, including reducing growth, enhancing cancer cell death and reducing drug resistance. Our research is focused on the repurposing of dichloroacetate (DCA), an old, non-toxic drug, to modify cancer cell metabolism and improve cancer therapy. A clinical trial of DCA in multiple myeloma patients is planned to commence later this year at The Canberra Hospital.
Dr Anneke Blackburn has been awarded the 2014 John James Foundation Tony Ayers Prize. This prize has been established by the John James Foundation for Excellence in Research in Translational Medicine at the ANU College of Medicine, Biology and Environment in honour of their long term Board member Mr Tony Ayers AC.
This lecture is free and open to the public.
Registration is required as the number of seats is strictly limited.
Enquiries or to RSVP:
T 02 6125 2577